Acute Asthma in the Emergency Room
|
|
|
- Dorcas Green
- 5 years ago
- Views:
Transcription
1 Acute Asthma in the Emergency Room José A. Castro-Rodríguez, MD, PhD Escuela de Medicina Pontificia Universidad Católica de Chile
2 Potential ConConflict of Interest: In the last three years, I received honoraries for advisor and lectures sponsor by: AstraZeneca, GlaxoSmithKline, MerckSharpDhone, and Novartis.
3 Levels of evidence 1 ++ High quality meta-analyses,, systematic reviews, or randomised controlled trials (RCTs) with a very low risk of bias 1 + Well-conducted meta-analyses, analyses, systematic reviews, or RCTs with a low risk of bias 1 Meta-analyses, analyses, systematic reviews, or RCTs with a high risk of bias Grades of recommendation Relate to strength of evidence, not clinical importance Low grade recommendations in important clinical areas should stimulate research Recommendation A Evidence At least one 1 ++ directly applicable to target population; ; or Many studies 1 + directly applicable to target population and demonstrating consistency 3 Introduction. Thorax 2003; 58 (Suppl I): i1-i92
4 Management for Acute Asthma MDI vs. Nebulizer Type of spacer devices Salbutamol vs. Salbutamol+Bromuro Ipatropio Salbutamol vs. Leva-Salbutamol Oral Corticosteroids Systemic vs. Inhaled Corticosteroids Heliox vs. Oxygen for nebulization salbutamol
5 β-agonists by MDI+VHC vs. by Nebulizers for Acute Exacerbation of Wheezing or Asthma in Children under 5 yrs Need of Hospitalization: 6 RCT (n=491) NTT=10 Risk of hospitalization is 58% less using β-agonists by MDI than by nebulizer Castro-Rodríguez JA & Rodrigo G. J of Pediatr 2004;145:172-7
6 β-agonists by MDI+VHC vs. by Nebulizers for Acute Exacerbation of Wheezing or Asthma in Children under 5 yrs Improvement of clinical score: Improvement of clinical score is 36% more using β-agonists by MDI than by nebulizer Castro-Rodríguez JA & Rodrigo G. J of Pediatr 2004;145:172-7
7 Management for Acute Asthma MDI vs. Nebulizer Type of spacer devices Salbutamol vs. Salbutamol+Bromuro Ipatropio Salbutamol vs. Leva-Salbutamol Oral Corticosteroids Systemic vs. Inhaled Corticosteroids Heliox vs. Oxygen for nebulization salbutamol
8 N=6 RCT (n=658) Rodriguez C et al. Cochr Data Base 2008
9 Management for Acute Asthma MDI vs. Nebulizer Type of spacer devices Salbutamol vs. Salbutamol+Bromuro Ipatropio Salbutamol vs. Leva-Salbutamol Oral Corticosteroids Systemic vs. Inhaled Corticosteroids Heliox vs. Oxygen for nebulization salbutamol
10 Combination of Anticholinergics to β2-agonits in Children with Acute Asthma Less Hospital Admission N=16 RCT, n=1786 children & adolescents NTT=13 Rodrigo GJ & Castro-Rodriguez JA.Thorax 2005
11 Combination of Anticholinergics to β2-agonits in Children with Acute Asthma Higher FEV1 improvement Rodrigo GJ & Castro-Rodriguez JA.Thorax 2005
12 Management for Acute Asthma MDI vs. Nebulizer Type of spacer devices Salbutamol vs. Salbutamol+Bromuro Ipatropio Salbutamol vs. Leva-Salbutamol Oral Corticosteroids Systemic vs. Inhaled Corticosteroids Heliox vs. Oxygen for nebulization salbutamol
13 Levalbuterol vs. Albuterol for Acute Ashtma N=7RCTs, n=1625 (only 1 in adults Nowak) Ram K, Khairwa A. Pulm Pharm & Therap 2013
14
15 Management for Acute Asthma MDI vs. Nebulizer Type of spacer devices Salbutamol vs. Salbutamol+Bromuro Ipatropio Salbutamol vs. Leva-Salbutamol Oral Corticosteroids Systemic vs. Inhaled Corticosteroids Heliox vs. Oxygen for nebulization salbutamol
16 Efficacy of Oral Corticosteroids in the Treatment of Acute Wheezing Episodes in Asthmatic Preschoolers
17 Management for Acute Asthma MDI vs. Nebulizer Type of spacer devices Salbutamol vs. Salbutamol+Bromuro Ipatropio Salbutamol vs. Leva-Salbutamol Oral Corticosteroids Systemic vs. Inhaled Corticosteroids Heliox vs. Oxygen for nebulization salbutamol
18 Inhaled vs. Systemic Corticosteroids for Acute Asthma in Children Hospitalizations N=8 RCT (2-18yrs), n=797 RR Beckhaus A, Riutort MC, Castro-Rodriguez JA. Pediatr Pulmonol 2014
19 Inhaled vs. Systemic Corticosteroids for Acute Asthma in Children N=8 RCT (2-18yrs), n=797 Need of additional systemic corticosteroids RR NBZ (1 RCT) RR: 0.12 (95% CI: 0.02 to 0.91), I 2 =0% pmdi (3 RCT) RR: 3.35 (95% CI: 1.20 to 9.35), I 2 =0% Beckhaus A, Riutort MC, Castro-Rodriguez JA. Pediatr Pulmonol 2014
20 Management for Acute Asthma MDI vs. Nebulizer Type of spacer devices Salbutamol vs. Salbutamol+Bromuro Ipatropio Salbutamol vs. Leva-Salbutamol Oral Corticosteroids Systemic vs. Inhaled Corticosteroids Heliox vs. Oxygen for nebulization salbutamol
21 Heliox- driven β2-agonists Nebulization for children & adults with acute asthma: a sistematic review/meta-analysis 11 RCT (3 RCT children, n=113) mean 120 min He 70:30 Mean change in Asthma or pulmonary composite score Rodrigo G & Castro-Rodriguez, Allergy 2013
22 Heliox- driven β2-agonists Nebulization for children & adults with acute asthma: a sistematic review/meta-analysis 11 RCT (3 RCT children, n=113) mean 120 min He 70:30 Hospitalizations Rodrigo G & Castro-Rodriguez, Allergy 2013
23 Conclusions: Management Acute Asthma -Salbutamol by MDI is better than by nebulizer -Valvulate and non-valvulate spacer device are similar -Salbutamol is equal to Leva-salbutalmol -Bromuro ipatropio + salbutamol is better than salbutamol (moderate/severe exacerbations) -Oral Corticosteroids is effectiveness only at the ED (not a home) -Inhaled Corticosteroids is similar to systemic corticosteroids -Nebulization salbutamol w/heliox is better than w/oxygeno (severe exacerbations)
24 Muito Obrigado Muchas Gracias Thanks!
Predicting, Preventing and Managing Asthma Exacerbations. Heather Zar Department of Paediatrics & Child Health University of Cape Town South Africa
Predicting, Preventing and Managing Asthma Exacerbations Heather Zar Department of Paediatrics & Child Health University of Cape Town South Africa Asthma exacerbations Predicting exacerbation recognising
Supplementary Medications during asthma attack. Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus
Supplementary Medications during asthma attack Prof. Dr Finn Rasmussen PhD. DrMedSc. Near East University Hospital North Cyprus Conflicts of Interest None Definition of Asthma Airway narrowing that is
Kirthi Gunasekera MD Respiratory Physician National Hospital of Sri Lanka Colombo,
Kirthi Gunasekera MD Respiratory Physician National Hospital of Sri Lanka Colombo, BRONCHODILATORS: Beta Adrenoreceptor Agonists Actions Adrenoreceptor agonists have many of the same actions as epinephrine/adrenaline,
Rapid Effects of Inhaled Corticosteroids in Acute Asthma Gustavo J. Rodrigo, MD.
Rapid Effects of Inhaled Corticosteroids in Acute Asthma Gustavo J. Rodrigo, MD WWW.chestjournal.org Background: Current reviews on the use of inhaled corticosteroids (ICS) for acute asthma underestimated
Management of Acute Asthma Exacerbations in Children 2012 Update. Sharon Kling Dept Paediatrics & Child Health University of Stellenbosch
Management of Acute Asthma Exacerbations in Children 2012 Update Sharon Kling Dept Paediatrics & Child Health University of Stellenbosch Acknowledgements BTS/SIGN guidelines GINA guidelines NAEPP guidelines
Acute Wheezing Emergencies: From Young to Old! Little Wheezers in the ED: Managing Acute Pediatric Asthma
Acute Wheezing Emergencies: From Young to Old! Little Wheezers in the ED: Managing Acute Pediatric Asthma Talk Outline Case Delivery of bronchodilators Meter-dose inhalers and spacers Continuous nebulization
TREAMENT OF RECURRENT VIRUS-INDUCED WHEEZING IN YOUNG CHILDREN. Dr Lại Lê Hưng Respiratory Department
TREAMENT OF RECURRENT VIRUS-INDUCED WHEEZING IN YOUNG CHILDREN Dr Lại Lê Hưng Respiratory Department Literature review current through: Feb 2013. This topic last updated: Aug 14, 2012 INTRODUCTION Wheezing
DATE: 09 December 2009 CONTEXT AND POLICY ISSUES:
TITLE: Tiotropium Compared with Ipratropium for Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease: A Review of the Clinical Effectiveness DATE: 09 December 2009 CONTEXT AND POLICY
The adult therapeutic substitution protocol follows:
Therapeutic Substitution of Albuterol - Implemented 1/15/2013 After years of evaluation, comparative studies have not consistently demonstrated clinical or safety advantages of levalbuterol over racemic
Lecture Notes. Chapter 3: Asthma
Lecture Notes Chapter 3: Asthma Objectives Define asthma and status asthmaticus List the potential causes of asthma attacks Describe the effect of asthma attacks on lung function List the clinical features
PEDIATRIC ACUTE ASTHMA SCORE (P.A.A.S.) GUIDELINES. >97% 94% to 96% 91%-93% <90% Moderate to severe expiratory wheeze
Inclusion: Children experiencing acute asthma exacerbation 24 months to 18 years of age with a diagnosis of asthma Patients with a previous history of asthma (Consider differential diagnosis for infants
Metered Dose Inhalers with Valved Holding Chamber: A Pediatric Hospital Experience
Metered Dose Inhalers with Valved Holding Chamber: A Pediatric Hospital Experience 8th Annual North Regional Respiratory Care Conference Minnesota & Wisconsin Societies for Respiratory Care Mayo Civic
Tips on managing asthma in children
Tips on managing asthma in children Dr Ranjan Suri Consultant in Respiratory Paediatrics Bupa Cromwell Hospital Clinics: Friday (pm) Asthma in Children Making the diagnosis Patterns of childhood asthma
Pediatric asthma is the most commonly encountered
Noel A. Dunn, MD; Laurel A. Neff, DO; Douglas M. Maurer, DO, MPH Department of Family Medicine, Madigan Army Medical Center, Tacoma, Wash (Drs. Dunn, Neff, and Maurer) douglas.m.maurer.mil@ mail.mil The
Episode 79 Pediatric Asthma
Reliable Validated Measures of Pediatric Asthma Episode 79 Pediatric Asthma With Dr. Dennis Scolnik & Dr. Sanjay Mehta Prepared by Dr. Anton Helman, April 2016 Pediatric Asthma Severity Indicators life-threatening
INPATIENT ASTHMA CARE PROTOCOL
INPATIENT ASTHMA CARE PROTOCOL When ordered by a physician, an eligible child 2 years of age or older who is admitted to the General Pediatric Inpatient Unit at the Children s Hospital of Georgia with
Asthma and COPD in the ICU
Asthma and COPD in the ICU Prescott Woodruff, MD, MPH Assistant Professor Medicine in Residence Pulmonary and Critical Care Medicine, Department of Medicine Acute Exacerbations of Asthma Asthma exacerbations
Management of wheeze in pre-school children. Prof Colin Robertson, Respiratory Medicine, Royal Children s Hospital, Melbourne
Management of wheeze in pre-school children Prof Colin Robertson, Respiratory Medicine, Royal Children s Hospital, Melbourne General Practitioner encounters for asthma Asthma in Australia, 2003 Emergency
Wheezy? Easy Peasy! The Emergent Management of Asthma & Bronchiolitis. Maneesha Agarwal MD Assistant Professor of Pediatrics & Emergency Medicine
Wheezy? Easy Peasy! The Emergent Management of Asthma & Bronchiolitis Maneesha Agarwal MD Assistant Professor of Pediatrics & Emergency Medicine Asthma Defined National Asthma Education and Prevention
Inhaled short-acting bronchodilators for managing emergency childhood asthma: an overview of reviews
Allergy REVIEW ARTICLE Inhaled short-acting bronchodilators for managing emergency childhood asthma: an overview of reviews M. Pollock 1, I. P. Sinha 2, L. Hartling 1, B. H. Rowe 3, S. Schreiber 1 & R.
NEBULIZED SALBUTAMOL WITH & WITHOUT IPRATROPIUM BROMIDE IN THE TREATMENT OF ACUTE SEVERE ASTHMA
NEBULIZED SALBUTAMOL WITH & WITHOUT IPRATROPIUM BROMIDE IN THE TREATMENT OF ACUTE SEVERE ASTHMA Naveed Inayat*, Riaz Hussain Shah**, Qurban Ali Rahu***, Rubina Sahito* ORIGINAL ARTICLE *Department of Pulmonology,
Outcome, classification and management of wheezing in preschool children Paul L.P. Brand
Outcome, classification and management of wheezing in preschool children Paul L.P. Brand Princess Amalia Children s Clinic Isala klinieken, Zwolle the Netherlands p.l.p.brand@isala.nl Valle de la Luna,
AT TRIAGE. Alberta Acute Childhood Asthma Pathway: Evidence based* recommendations For Emergency / Urgent Care
1 1 Should the child be placed into the Pathway? Asthma Clinical Score (PRAM) Inclusion Children 1 year and 18 years of age who present with wheezing and respiratory distress, and have been diagnosed by
Effectiveness of Asthma Education with and Without a Self-Management Plan in Hospitalized Children
Journal of Asthma, 46:906 910, 2009 Copyright C 2009 Informa Healthcare USA, Inc. ISSN: 0277-0903 print / 1532-4303 online DOI: 10.3109/02770900903199979 ORIGINAL ARTICLE Effectiveness of Asthma Education
Recurrent wheezing illnesses 24.9% Similar to Australia Above global averages
Prof Mike South Department of General Medicine Royal Children s Hospital Melbourne Australia www.mikesouth.org.au Asthma is very common in Australia Approx 25% children have recurrent wheezing illnesses
Preschool Wheeze. AC Jeevarathnum 04/03/16. Paediatric Pulmonologist Steve Biko Academic Hospital
Preschool Wheeze AC Jeevarathnum Paediatric Pulmonologist Steve Biko Academic Hospital MBBCh FcPaed(SA) MMED Dip Allergy(SA) Cert Pulm(Paed)(SA) European Respiratory Diploma 04/03/16 Overview Introduction
Emergency Department Protocol Initiative
Emergency Department Protocol Initiative ACUTE ASTHMA MANAGEMENT TOOLKIT March 2006 Provincial Emergency Services Project PHYSICIAN ORDER TEMPLATE FOR CTAS LEVEL 1 ASTHMA ADULT PEDIATRIC Date: Site: Arrival
Drug Class Review on Quick-relief Medications for Asthma
Drug Class Review on Quick-relief Medications for Asthma Preliminary Scan Report #3 November 2013 The Agency for Healthcare Research and Quality has not yet seen or approved this report The purpose of
Asthma in Pregnancy. Asthma. Chronic Airway Inflammation. Objective Measures of Airflow. Peak exp. flow rate (PEFR)
Chronic Airway Inflammation Asthma in Pregnancy Robin Field, MD Maternal Fetal Medicine Kaiser Permanente San Francisco Asthma Chronic airway inflammation increased airway responsiveness to a variety of
2/12/2015. ASTHMA & COPD The Yin &Yang. Asthma General Information. Asthma General Information
ASTHMA & COPD The Yin &Yang Arizona State Association of Physician Assistants March 6, 2015 Sedona, Arizona Randy D. Danielsen, PhD, PA-C, DFAAPA Dean & Professor A.T. Still University Asthma General Information
COPD: Current Medical Therapy
COPD: Current Medical Therapy Angela Golden, DNP, FNP-C, FAANP Owner, NP from Home, LLC Outcomes As a result of this activity, learners will be able to: 1. List the appropriate classes of medications for
Nguyen Tien Dung A/Prof. PhD. MD Head of Pediatric Department - Bach Mai Hospital
Nguyen Tien Dung A/Prof. PhD. MD Head of Pediatric Department - Bach Mai Hospital A girl patient 11 years old admitted to Bach mai Hospital at 4h15, 12nd November because of difficult breathing She has
Quality Design Limitations Inconsistency Indirectness Imprecision studies. Other. considerations Heliox Control (95% Absolute
Question 7: In the child with asthma exacerbation in the ED, should heliox driven albuterol vs. oxygen or room air driven albuterol be used to prevent hospitalization, decrease time in the ED or improve
10/6/2014. Tommy s Story: An Overview of Asthma Mangement. Disclosure. Objectives for this talk.
Tommy s Story: An Overview of Asthma Mangement Clifton C. Lee, MD, FAAP, FHM Associate Professor of Pediatrics Chief, Pediatric Hospital Medicine Children s Hospital of Richmond at VCU Disclosure Obviously,
Breaking Down Barriers to Pulmonary Therapies: Patient Education, Teach Back, and More
Breaking Down Barriers to Pulmonary Therapies: Patient Education, Teach Back, and More Char Raley, RRT Brandon Johnson, PharmD, BCPS Pulmonary and Critical Care Symposium June 12 th, 2015 We have had no
Anticholinergic therapy for acute asthma in children(review)
Cochrane Database of Systematic Reviews Anticholinergic therapy for acute asthma in children(review) TeohL,CatesCJ,HurwitzM,AcworthJP,vanAsperenP,ChangAB TeohL,CatesCJ,HurwitzM,AcworthJP,vanAsperenP,ChangAB.
Systematic Review on Efficacy of Magnesium (Intravenous or Nebulized) for Acute Asthma Episodes in Children
J O U R N A L C L U B Systematic Review on Efficacy of Magnesium (Intravenous or Nebulized) for Acute Asthma Episodes in Children Source Citation: Su Z, Li R, Gai Z. Intravenous and nebulized magnesium
Impact of levalbuterol versus Albuterol in Kentucky Medicaid Patients
University of Kentucky UKnowledge MPA/MPP Capstone Projects Martin School of Public Policy and Administration 2010 Impact of levalbuterol versus Albuterol in Kentucky Medicaid Patients Velma Henry University
PEDIATRIC ASTHMA INPATIENT CARE MAP
DATE PATIENT PEDIATRIC ASTHMA INPATIENT CARE MAP DOB HSC NO. PHIN Approved by the Winnipeg Regional Health Authority This Care Map is to be used as a guideline and in no way replaces sound clinical judgment
VA/DoD Clinical Practice Guideline Management of COPD Pocket Guide
VA/DoD Clinical Practice Guideline Management of COPD Pocket Guide MODULE A: MAAGEMET OF COPD 1 2 Patient with suspected or confirmed COPD presents to primary care [ A ] See sidebar A Perform brief clinical
Efficacy of Nebulised Ipratropium in Acute Bronchial Asthma
ORIGINAL ARTICLE JIACM 2002; 3(4): 353-59 Efficacy of Nebulised Ipratropium in Acute Bronchial Asthma Praveen Aggarwal*, Onkar Singh**, Jyoti P Wali***, Rohini Handa*, Sada N Dwivedi****, Ashutosh Biswas*****,
THE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Vol 120 No 1267 ISSN 1175 8716 Is Salamol less effective than Ventolin? A randomised, blinded, crossover study in New Zealand Catherina L Chang, Manisha Cooray, Graham Mills,
Patient adherence to inhaled therapy A clinical perspective. Nicolas Roche Cochin, Site Val de Grâce University Paris Descartes, Paris, France
Patient adherence to inhaled therapy A clinical perspective Nicolas Roche Cochin, Site Val de Grâce University Paris Descartes, Paris, France 1 Disclosures Aerocrine Almirall AstraZeneca Boehringer Ingelheim
2017 GOLD Report. Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017
2017 GOLD Report Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017 Lauren Munro; BSc(Pharm) Amanda Burns; BSc(Pharm) Pharmacy Residents The Moncton Hospital Objectives Explain
High-dose nebulized budesonide is effective for mild asthma exacerbations in children under 3 years of age
O R I G I N A L A R T I C L E S Eur Ann Allergy Clin Immunol Vol 49, N 1, 22-27, 2017 M. Saito 1, Y. Kikuchi 1, A. Kawarai Lefor 2, M. Hoshina 1 High-dose nebulized budesonide is effective for mild asthma
SHORT COMMUNICATION. Abstract. Kevin R. Murphy, 1 Tom Uryniak, 2 Ubaldo J. Martin 2 and James Zangrilli 2
SHORT COMMUNICATION Drugs R D 212; 12 (1): 9-14 1179-691/12/1-9 ª 212 Murphy et al., publisher and licensee Adis Data Information BV. This is an open access article published under the terms of the Creative
+ Asthma and Athletics
+ Asthma and Athletics Shaylon Rettig, MD, MBA Champion Sports Medicine + Financial Disclosure Dr. Shaylon Rettig has no relevant financial relationships with commercial interests to disclose. + Asthma
The pharmacologic treatment of acute severe asthma includes high-dose inhaled bronchodilators and the early
Efficacy of adding multiple doses of oxitropium bromide to salbutamol delivered by means of a metered-dose inhaler with a spacer device in adults with acute severe asthma Yutaka Nakano, MD, a Noriyuki
Practical Approach to Managing Paediatric Asthma
Practical Approach to Managing Paediatric Asthma Dr Andrew Tai FRACP, PhD Paediatric Respiratory and Sleep Specialist Women's and Children's Hospital, Adelaide Approaching the patient Check the diagnosis
ARTICLE. Annette Delgado, MD; Katherine J. Chou, MD; Ellen Johnson Silver, PhD; Ellen F. Crain, MD, PhD
ARTICLE Nebulizers vs Metered-Dose Inhalers With Spacers for Bronchodilator Therapy to Treat Wheezing in Children Aged 2 to 24 Months in a Pediatric Emergency Department Annette Delgado, MD; Katherine
Presented by UIC College of Nursing
Presented by UIC College of Nursing Describe COPD. Identify red flags for a COPD exacerbation. Identify COPD triggers or risk factors. Differentiate between long-acting inhalers and emergency use inhalers.
Chronic Obstructive Pulmonary Disease 1/18/2018
Presented by UIC College of Nursing Describe COPD. Identify red flags for a COPD exacerbation. Identify COPD triggers or risk factors. Differentiate between long acting inhalers and emergency use inhalers.
LINEE GUIDA DELL ASMA: UP TO DATE
LINEE GUIDA DELL ASMA: UP TO DATE Azienda Ospedaliera Pisana Università degli Studi di Pisa Pierluigi Paggiaro GINA International Executive Committee, Chairman GINA ITaly Cardio-Thoracic and Vascular Department,
The problem with critical and non-critical inhaler errors
The problem with critical and non-critical inhaler errors Federico Lavorini MD, PhD Dept. Experimental and Clinical Medicine Careggi University Hospital Florence, Italy Presenter disclosures Federico Lavorini
Asthma Update A/Prof. John Abisheganaden. Senior Consultant, Dept Of Respiratory & Crit Care Medicine Tan Tock Seng Hospital
Asthma Update - 2013 A/Prof. John Abisheganaden Senior Consultant, Dept Of Respiratory & Crit Care Medicine Tan Tock Seng Hospital Asthma A complex syndrome Multifaceted disease Heterogeneous Genetic and
Early use of inhaled corticosteroids in the emergency department treatment of acute asthma (Review)
Early use of inhaled corticosteroids in the emergency department treatment of acute asthma (Review) Edmonds ML, Milan SJ, Camargo Jr CA, Pollack CV, Rowe BH This is a reprint of a Cochrane review, prepared
Treatment of asthma in young children: evidence-based recommendations
Castro-Rodriguez et al. Asthma Research and Practice (2016) 2:5 DOI 10.1186/s40733-016-0020-z REVIEW Treatment of asthma in young children: evidence-based recommendations Jose A. Castro-Rodriguez 1*, Adnan
Evolution of asthma from childhood. Carlos Nunes Center of Allergy and Immunology of Algarve, PT
Evolution of asthma from childhood Carlos Nunes Center of Allergy and Immunology of Algarve, PT allergy@mail.telepac.pt Questionnaire data Symptoms occurring once or several times at follow-up (wheeze,
Wheezing-associated illnesses are a major cause of morbidity in infants and preschool children, with acute exacerbation
b-agonists THROUGH METERED-DOSE INHALER WITH VALVED HOLDING CHAMBER VERSUS NEBULIZER FOR ACUTE EXACERBATION OF WHEEZING OR ASTHMA IN CHILDREN UNDER 5 YEARS OF AGE: A SYSTEMATIC REVIEW WITH META-ANALYSIS
Patient characteristics Intervention Comparison Length of followup
ORAL MUCOLYTICS Ref ID: 2511 Bachh AA, Shah NN, Bhargava R et al. Effect oral N- in COPD - A randomised controlled trial. JK Practitioner. 2007; 14(1):12-16. Ref ID: 2511 RCT Single blind; unclear allocation
Asthma in the Athlete
Asthma in the Athlete Jorge E. Gomez, MD Associate Professor Texas Children s Hospital Baylor College of Medicine Assist Team Physician UH Understand how we diagnose asthma Objectives Be familiar with
Inhaler Confusion. Today s Speaker Dr. Randall Brown. Director of Asthma Programs 6/7/2016. Dr. Randall Brown March 31, 2016
+ Inhaler Confusion Dr. Randall Brown March 31, 2016 + Today s Speaker Dr. Randall Brown Director of Asthma Programs Center for Managing Chronic Disease University of Michigan 1 ASTHMA ESSENTIALS IN PRIMARY
Optimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center
Optimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center dtaylor@ochsner.org Observations from Yesterday EPIC is epidemic No EMR No Way!!! Accountability/Benchmarking
Correlations between pulse oximetry and peak expiratory flow in acute asthma
Brazilian Journal of Medical and Biological Research (2007) 40: 485-490 Pulse oximetry and peak expiratory flow in acute asthma ISSN 0100-879X 485 Correlations between pulse oximetry and peak expiratory
Drug Class Review. Quick-relief Medications for Asthma
Drug Class Review Quick-relief Medications for Asthma Final Update 1 Report Evidence Tables October 2008 The purpose of reports is to make available information regarding the comparative clinical effectiveness
The Acute & Maintenance Treatment of Asthma via Aerosolized Medications
The Acute & Maintenance Treatment of Asthma via Aerosolized Medications Douglas S. Gardenhire, EdD, RRT-NPS, FAARC Associate Professor and Chairman Department of Respiratory Therapy Objectives Define Asthma.
SYNOPSIS. Drug substance(s) Budesonide/formoterol Document No. Edition No. Study code SD Date 16 December 2004
Drug product SYMBICORT pmdi 160/4.5 µg SYNOPSIS Drug substance(s) Budesonide/formoterol Document No. Edition No. Date 16 December 2004 A Twelve-Week, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled
Bronchodilator Delivery and Nebuliser Trials in Adults
Bronchodilator Delivery and Nebuliser Trials in Adults Acute Management Favour the use of MDI (+/- Spacer) If considering nebuliser Short term treatment Approx. < 3 weeks See optimisation of inhaled bronchodilators
Office Asthma Care: Practical Elements of Asthma Management. Learning Objectives. Diagnosis
Office Asthma Care: Practical Elements of Asthma Management Pri-Med West Annual Conference March 29, 2014 Anaheim, CA Sande Okelo, MD, PhD, University of California Los Angeles sokelo@mednet.ucla.edu www.uclahealth.org/pedspulmonology
Omalizumab (Xolair ) ( Genentech, Inc., Novartis Pharmaceuticals Corp.) September Indication
( Genentech, Inc., Novartis Pharmaceuticals Corp.) September 2003 Indication The FDA recently approved Omalizumab on June 20, 2003 for adults and adolescents (12 years of age and above) with moderate to
Asthma. No financial relationships with a commercial interest to disclose
Asthma in the ED Emily Rose, MD FAAP FAAEM FACEP Assistant Professor of Clinical Emergency Medicine Keck School of Medicine of USC LA County + USC Medical Center No financial relationships with a commercial
T reatment of acute asthma includes inhaled short acting
ASTHMA Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis G J Rodrigo, J A Castro-Rodriguez...... Correspondence to: Dr G J Rodrigo, Departamento
Pathology of Asthma Epidemiology
Asthma A Presentation on Asthma Management and Prevention What Is Asthma? A chronic disease of the airways that may cause Wheezing Breathlessness Chest tightness Nighttime or early morning coughing Pathology
Asma, BPCO ed Esercizio Fisico Ferrara, 6 e 7 Novembre Overlap asma BPCO. Dr. Marco Contoli
Asma, BPCO ed Esercizio Fisico Ferrara, 6 e 7 Novembre 2015 Overlap asma BPCO Dr. Marco Contoli Sezione di Medicina Interna e Cardio-Respiratoria Dipartimento di Scienze Mediche Università di Ferrara (Sept.
Ivax Pharmaceuticals UK Sponsor Submission to the National Institute for Health and Clinical Excellence
Ivax Pharmaceuticals UK Sponsor Submission to the National Institute for Health and Clinical Excellence Clinical and cost-effectiveness of QVAR for the treatment of chronic asthma in adults and children
Controversial Issues in the Management of Childhood Asthma: Insights from NIH Asthma Network Studies
Controversial Issues in the Management of Childhood Asthma: Insights from NIH Asthma Network Studies Stanley J. Szefler, MD Helen Wohlberg and Herman Lambert Chair in Pharmacokinetics, Head, Pediatric
Interventions to improve adherence to inhaled steroids for asthma. Respiratory department
Interventions to improve adherence to inhaled steroids for asthma Respiratory department Content Overview Research References Overview Asthma is a chronic breathing condition that affects more than 300
Brooke L. Gildon, Pharm.D., BCPS, BCPPS, AE C
Brooke L. Gildon, Pharm.D., BCPS, BCPPS, AE C Associate Professor of Pharmacy Practice Southwestern Oklahoma State University College of Pharmacy Oklahoma Society of Health System Pharmacists Annual Meeting
Asthma is global health problem in children,
Paediatrica Indonesiana VOLUME 52 July NUMBER 4 Original Article Efficacy of salbutamol-ipratropium bromide nebulization compared to salbutamol alone in children with mild to moderate asthma attacks Matahari
TORCH: Salmeterol and Fluticasone Propionate and Survival in COPD
TORCH: and Propionate and Survival in COPD April 19, 2007 Justin Lee Pharmacy Resident University Health Network Outline Overview of COPD Pathophysiology Pharmacological Treatment Overview of the TORCH
Nebulizer versus inhaler with spacer for beta-agonist treatment in acute bronchospastic disease
Hong Kong Journal of Emergency Medicine Nebulizer versus inhaler with spacer for beta-agonist treatment in acute bronchospastic disease β GPC Lee, WY Sung, HT Fung, CW Kam Objectives: To compare the efficacy
Treatment choices for patients with asthma or COPD. Jo Riley Lead Nurse For Oxfordshire Respiratory Service
Treatment choices for patients with asthma or COPD Jo Riley Lead Nurse For Oxfordshire Respiratory Service What is the difference? Is it all about? Inhaled steroids Long acting ß2 agonists Short acting
Intravenous and nebulized magnesium sulfate for treating acute asthma in adults and children: A systematic review and meta-analysis
Respiratory Medicine (2013) 107, 321e330 Available online at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed REVIEW Intravenous and nebulized magnesium sulfate for treating acute asthma
Diagnosis, Treatment and Management of Asthma
Diagnosis, Treatment and Management of Asthma Asthma is a complex disorder characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation.
Safety of long-acting b agonists for the treatment of asthma: clearing the air
1 Department of Emergency, Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay 2 Departments of Pediatrics and Family Medicine, School of Medicine, Pontificia Universidad Católica de Chile, Santiago,
Pediatric Respiratory Disease: A Model for the Future of Emergency Medicine Research
Pediatric Respiratory Disease: A Model for the Future of Emergency Medicine Research Joseph J. Zorc, MD, MSCE Mark Fishman Professor, Department of Pediatrics Perelman School of Medicine, University of
Inhaled Corticosteroids for the Treatment of Chronic Asthma in Adults & Adolescents aged 12 years & over
Manufacturer Submission To The National Institute for Health and Clinical Excellence By GlaxoSmithKline UK Inhaled Corticosteroids for the Treatment of Chronic Asthma in Adults & Adolescents aged 12 years
Randomised controlled trial of aminophylline for severe acute asthma
Arch Dis Child 1998;79:405 410 405 Intensive Care Unit, Royal Children s Hospital, Melbourne, Victoria 3052, Australia M Yung M South Correspondence to: Dr South. email: south@cryptic.rch. unimelb.edu.au
Integrating Evidence-Based Pediatric Prehospital Protocols into Practice EMSC Targeted Issues Grant #H34MC19347 ASK THE QUESTION Question 1:
Integrating Evidence-Based Pediatric Prehospital Protocols into Practice EMSC Targeted Issues Grant #H34MC19347 Children with Respiratory Distress Prehospital Protocol Evidence-Based Practice Summary ASK
Disclosure. Case. Objectives. Case Continued. Inhalers. Asthma: A GINA Update to the NAEPP 2007 Guidelines 1/20/2015
Disclosure Asthma: A GINA Update to the NAEPP 2007 Guidelines Robert (RC) Hellinga, Pharm.D. PGY 1 Pharmacy Resident Wolfson Children s Hospital/Baptist Health I do not have a vested interest in or affiliation
ORIGINAL ARTICLE ABSTRACT SUMMARY AT A GLANCE INTRODUCTION
bs_bs_banner ORIGINAL ARTICLE Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: A randomized, double-blind, placebo-controlled study AI-HUAN CHEN,*
Advanced Pediatric Emergency Medicine Assembly
(+)Charles Macias, MD, FACEP Associate Professor of, Section of Emergency Medicine, Baylor College of Medicine; Director, Evidence Based Outcomes Center and Center for Clinical Effectiveness, Baylor College
Asthma Exacerbation Management in Children. Kong-Sang Wan, MD,PhD 温港生醫師 台北市聯合醫院仁愛院區小兒科
Asthma Exacerbation Management in Children Kong-Sang Wan, MD,PhD 温港生醫師 台北市聯合醫院仁愛院區小兒科 Hypocapnia & respiratory alkalosis due to increase resp. rate Symptom classification Severe persistent - day: continue
Treatment. Assessing the outcome of interventions Traditionally, the effects of interventions have been assessed by measuring changes in the FEV 1
58 COPD 59 The treatment of COPD includes drug therapy, surgery, exercise and counselling/psychological support. When managing COPD patients, it is particularly important to evaluate the social and family
Sponsor. Generic drug name. Trial indication(s) Protocol number. Protocol title. Clinical trial phase. Study Start/End Dates.
Sponsor Novartis Generic drug name Fluticasone propionate Trial indication(s) Moderate-severe bronchial asthma Protocol number CQAE397A2202 Protocol title A randomized open label study to assess the utility
Greater Manchester Asthma Management Plan 2018 Inhaler therapy options for adult patients (18 and over) with asthma
Greater Manchester Asthma Management Plan 2018 Inhaler therapy options for adult patients (18 and over) with asthma Non-pharmacological options for ALL patients, consider at ALL stages Make sure diagnosis
Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
Pharmacokinetics, pharmacodynamics, and the delivery of pediatric bronchodilator therapy
Pharmacokinetics, pharmacodynamics, and the delivery of pediatric bronchodilator therapy David P. Skoner, MD Pittsburgh, Pa β 2 -adrenergic receptor agonists have long been used for the amelioration of
Personalized medicine in childhood asthma. Dr Mariëlle Pijnenburg, Erasmus MC Sophia, Rotterdam, NL
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS for your personal use only, as submitted by the author.